Changes in fibrosis and MELD scores in HCV positive cirrhosis after direct-acting antiviral therapy

被引：0
|
作者：
Akin, Mete [1 ]
Bizhe, Rehim [1 ]
机构：
[1] Akdeniz Univ, Sch Med, Antalya, Turkey
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2019年 / 34卷
关键词：
Hepatitis C; fibrosis; Direct acting antivirals; noninvasive serologic methods;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PP 0380
引用
收藏
页码：264 / 264
页数：1
相关论文
共 50 条
  • [1] Mortality during direct-acting antiviral therapy in HCV/HIV patients with cirrhosis
    Vivancos-Gallego, Maria J.
    Moreno, Ana
    Perez Elias, Maria J.
    Quereda, Carmen
    Luis Casado, Jose
    Gomez Ayerbe, Cristina
    Sanchez-Conde, Matilde
    Del Campo, Santos
    Moreno, Santiago
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [2] Direct-Acting Antiviral Therapy and Purgatory MELD: Fact or Fiction?
    Cholankeril, George
    Perumpail, Ryan B.
    Yoo, Eric R.
    Hu, Menghan
    Ahmed, Aijaz
    Saab, Sammy
    Gonzalez, Stevan A.
    Beckerman, Rachel
    HEPATOLOGY, 2016, 64 : 423A - 424A
  • [3] Blood microbiome is associated with changes in portal hypertension after successful direct-acting antiviral therapy in patients with HCV-related cirrhosis
    Virseda-Berdices, Ana
    Brochado-Kith, Oscar
    Diez, Cristina
    Hontanon, Victor
    Berenguer, Juan
    Gonzalez-Garcia, Juan
    Rojo, David
    Fernandez-Rodriguez, Amanda
    Ibanez-Samaniego, Luis
    Llop-Herrera, Elba
    Olveira, Antonio
    Perez-Latorre, Leire
    Barbas, Coral
    Rava, Marta
    Resino, Salvador
    Jimenez-Sousa, Maria Angeles
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (03) : 719 - 726
  • [4] Direct-acting antiviral treatment for HCV
    Goutzamanis, Stelliana
    Doyle, Joseph
    Thompson, Alexander
    Hellard, Margaret
    Higgs, Peter
    LANCET INFECTIOUS DISEASES, 2016, 16 (12): : 1325 - 1326
  • [5] Changes in liver fibrosis in patients with chronic hepatitis C after successful direct-acting antiviral therapy
    Sadeghi, Anahita
    Amiri, Roya
    Akbarpour, Elham
    Mirminachi, Babak
    Sharifi, Amir-Houshang
    Merat, Shahin
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (06)
  • [6] Noninvasive Liver Fibrosis Markers in the Evaluation of Fibrosis Regression After Direct-Acting Antiviral Therapy
    Collazos, Julio
    Asensi, Victor
    JOURNAL OF INFECTIOUS DISEASES, 2024, 229 (06): : 1926 - 1927
  • [7] Changes in Utilization and Discard of HCV Antibody-Positive Deceased Donor Kidneys in the Era of Direct-Acting Antiviral Therapy
    Bowring, Mary G.
    Kucirka, Lauren M.
    Massie, Allan B.
    Ishaque, Tanveen
    Bae, Sunjae
    Shaffer, Ashton A.
    Wang, Jacqueline Garonzik
    Sulkowski, Mark
    Desai, Niraj
    Segev, Dorry L.
    Durand, Christine M.
    TRANSPLANTATION, 2018, 102 (12) : 2088 - 2095
  • [8] Long-Term Impact of Direct-Acting Antiviral Agent Therapy in HCV Cirrhosis: Critical Review
    Fehily, Sasha R.
    Papaluca, Tim
    Thompson, Alexander J.
    SEMINARS IN LIVER DISEASE, 2019, 39 (03) : 341 - 353
  • [9] RISK OF HEPATOCELLULAR CARCINOMA IN HCV-RELATED CIRRHOSIS TREATED WITH DIRECT-ACTING ANTIVIRAL (DAA) THERAPY
    Kilany, Shimaa
    Gomaa, Asmaa Ibrahim
    Sabry, Alyaa
    Moaz, Inas
    Ezzat, Sameera
    Badra, Gamal Ahmed
    Waked, Imam
    HEPATOLOGY, 2019, 70 : 321A - 322A
  • [10] Comprehensive immune changes associated with HCV direct-acting antiviral cures
    Slauenwhite, D.
    Arseneault, K.
    Brisseau, C.
    Oldford, S.
    Barrett, L.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S538 - S539
12345